Jacob G. Imber, MD
Article
P2Y12 Inhibitor Monotherapy After 1-3 Months of DAPT Reduces Major Bleeding Risk Without Increasing Ischemic Risk After Complex PCI
October 2, 2023
Clinical question: Does P2Y12 inhibitor monotherapy after one to three months of dual antiplatelet therapy (DAPT) improve clinical decrease in major bleeding risk without increasing ischemic risk in...
![1]()
News
Gram-negative bacteremia: Cultures, drugs, and duration
July 29, 2019
Management of gram-negative bacteremia remains a challenging clinical situation for inpatient providers.
